Voices
Freddy E. Escorcia: Study Combining Radiopharmaceuticals and CAR T Cells Against Neuroblastoma
Freddy E Escorcia/mskcc.org

Freddy E. Escorcia: Study Combining Radiopharmaceuticals and CAR T Cells Against Neuroblastoma

Freddy E Escorcia, Lasker Clinical Scholar and Radiation Oncologist at National Cancer Institute, shared a post on X:

“New work on radiopharmaceuticals immunology from our collaboration with Rosa Nguyen at National Cancer Institute and Ravi Patel! The interplay but radiopharmaceuticals therapy and the immune compartment is a hot topic !

Tons of work led by Constanza Rodriguez sheds some light!”

Title: A radiopharmaceutical enhances CAR T cells against radio-sensitive and radio-resistant neuroblastoma by tumor sensitization and TME remodeling

Authors: Constanza Rodriguez, Robert S. Edinger, George Diehl, Jeyshka M. Reyes-González, Woonghee Lee, John Buckley, Jangsuk Oh, Divya Nambiar, Kwamena Baidoo, Reona Okada, Ira Phadke, Zoe Schmiechen, Hannah Khan, Yash Sakhalkar, Angel G. Cortez, Anders Josefsson, Jessie R. Nedrow, Ayla White, Deborah E. Citrin, Xiyuan Zhang, Carolyn J. Anderson, Freddy E. Escorcia, Ravi B. Patel, Rosa Ng

Read the full article on Cell Reports Medicine.

Freddy E. Escorcia: Study Combining Radiopharmaceuticals and CAR T Cells Against Neuroblastoma

Other articles featuring Freddy E. Escorcia on OncoDaily.

Anders Josefsson Angel G. Cortez Ayla White cancer Carolyn J. Anderson Constanza Rodriguez Deborah E. Citrin Divya Nambiar Freddy E. Escorcia George Diehl Hannah Khan Ira Phadke Jangsuk Oh Jessie R. Nedrow Jeyshka M. Reyes-González John Buckley Kwamena Baidoo OncoDaily Oncology Ravi B. Patel Reona Okada Robert S. Edinger Rosa Ng Woonghee Lee Xiyuan Zhang Yash Sakhalkar Zoe Schmiechen